Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04051632 · ClinicalTrials.gov registry record
Analysis of Glycemic Control in Type 1 Diabetes Patients Using Hybrid Closed Loop Insulin Pump Therapy (Medtronic 670G)
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 96
- Enrollment target
NCT04051632: Completed study, sponsored by Boston Children's Hospital.
NCT04051632 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 96 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04051632 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
Observational study of patients at Boston Childrens Hospital with type 1 diabetes (T1D) who elected to treat their diabetes with the Medtronic 670 G hybrid closed loop insulin pump.
Primary Outcome
Percent of Type 1 Diabetes patients who were properly trained on the use of the 670G that continue to use Hybrid Closed Loop technology at 0, 6, 12, 18 and 24 months post training.
Interventions
- DEVICE Medtronic 670G insulin pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2018-06-13 |
| Est. Completion | 2019-07-30 |
What the finished NCT04051632 record still lists
NCT04051632 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 96 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Medtronic 670G insulin pump is the first listed.
NCT04051632 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04051632 about?
NCT04051632 is a clinical study titled "Analysis of Glycemic Control in Type 1 Diabetes Patients Using Hybrid Closed Loop Insulin Pump Therapy (Medtronic 670G)". Observational study of patients at Boston Childrens Hospital with type 1 diabetes (T1D) who elected to treat their diabetes with the Medtronic 670 G hybrid closed loop insulin pump.
What is the current status of trial NCT04051632?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2018-06-13. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT04051632?
The interventions under investigation include: Medtronic 670G insulin pump (DEVICE).
Who is sponsoring clinical trial NCT04051632?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI